Professor Sharon Peacock is an outstanding academic clinical microbiologist who combines scientific training with knowledge of clinical medicine to address questions of public health importance. Her research focus is the translation of high throughput whole genome sequencing technologies into diagnostic and public health microbiology, for which she has rapidly gained global eminence. This is a significant area of innovation, and the output from her group and collaborators places the UK at the forefront of this technological revolution. The focus for much of her recent scientific portfolio has been MRSA, but lessons and skills learnt are rapidly being applied to other pathogens of national and global importance, including Mycobacterium tuberculosis and multidrug resistant Gram-negative bacilli.
FellowBack to directory listing
Professor Sharon Peacock CBE FMedSci
Professor of Clinical Microbiology
London School of Hygiene and Tropical Medicine
diagnostic and public health microbiology, translation of microbial sequencing, antimicrobial resistance, pathogen transmission, tropical microbiology.
Section committee elected by
Surgery, anaesthesia, oncology, clinical pathologies, imaging (including radiology), dentistry, ophthalmology, obstetrics and gynaecology
5 most watched talks of 2018Read more
- about 12 minutes ago RT @kellymh6792: "Networking grants put the emphasis on what is important for your overseas partners" Perspectives from our #GCRFNetworkin…
- about 50 minutes ago As @MattHancock seeks to incentivise R&D for antimicrobial resistance drugs and treatments in #Davos, we we are wor… twitter.com/i/web/status/1…
- about 2 hours ago RT @DUK_research: Are you a research-active Clinical Lecturer looking to develop and strengthen your #research? You can apply for a @acmeds…
- about 4 hours ago Today Health Secretary @MattHancock warns attendees at #Davos “We are on the cusp of a world where a simple graze c… twitter.com/i/web/status/1…
- about 21 hours ago RT @Neuronal_K: 'Adequate reporting and transparency are key in #adaptivetrials acceptability' says @mdimairo #FORUM @acmedsci @The_MRC @NI…